Suppr超能文献

单细胞RNA测序揭示早期淋巴祖细胞间的发育异质性。

Single-cell RNA sequencing reveals developmental heterogeneity among early lymphoid progenitors.

作者信息

Alberti-Servera Llucia, von Muenchow Lilly, Tsapogas Panagiotis, Capoferri Giuseppina, Eschbach Katja, Beisel Christian, Ceredig Rhodri, Ivanek Robert, Rolink Antonius

机构信息

Developmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland

Developmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.

出版信息

EMBO J. 2017 Dec 15;36(24):3619-3633. doi: 10.15252/embj.201797105. Epub 2017 Oct 13.

Abstract

Single-cell RNA sequencing is a powerful technology for assessing heterogeneity within defined cell populations. Here, we describe the heterogeneity of a B220CD117CD19NK1.1 uncommitted hematopoietic progenitor having combined lymphoid and myeloid potential. Phenotypic and functional assays revealed four subpopulations within the progenitor with distinct lineage developmental potentials. Among them, the Ly6DSiglecHCD11c fraction was lymphoid-restricted exhibiting strong B-cell potential, whereas the Ly6DSiglecHCD11c fraction showed mixed lympho-myeloid potential. Single-cell RNA sequencing of these subsets revealed that the latter population comprised a mixture of cells with distinct lymphoid and myeloid transcriptional signatures and identified a subgroup as the potential precursor of Ly6DSiglecHCD11c Subsequent functional assays confirmed that B220CD117CD19NK1.1 single cells are, with rare exceptions, not bipotent for lymphoid and myeloid lineages. A B-cell priming gradient was observed within the Ly6DSiglecHCD11c subset and we propose a herein newly identified subgroup as the direct precursor of the first B-cell committed stage. Therefore, the apparent multipotency of B220CD117CD19NK1.1 progenitors results from underlying heterogeneity at the single-cell level and highlights the validity of single-cell transcriptomics for resolving cellular heterogeneity and developmental relationships among hematopoietic progenitors.

摘要

单细胞RNA测序是评估特定细胞群体异质性的一项强大技术。在此,我们描述了一种具有淋巴样和髓样双重潜能的B220CD117CD19NK1.1未定向造血祖细胞的异质性。表型和功能分析揭示了该祖细胞内具有不同谱系发育潜能的四个亚群。其中,Ly6DSiglecHCD11c亚群具有淋巴样限制性,表现出很强的B细胞潜能,而Ly6DSiglecHCD11c亚群则具有混合的淋巴样和髓样潜能。对这些亚群进行单细胞RNA测序发现,后一个群体包含具有不同淋巴样和髓样转录特征的细胞混合物,并鉴定出一个亚组作为Ly6DSiglecHCD11c的潜在前体。随后的功能分析证实,B220CD117CD19NK1.1单细胞,除极少数例外,对淋巴样和髓样谱系没有双潜能。在Ly6DSiglecHCD11c亚群中观察到一个B细胞启动梯度,我们提出在此新鉴定的一个亚组作为第一个B细胞定向阶段的直接前体。因此,B220CD117CD19NK1.1祖细胞明显的多潜能性源于单细胞水平上潜在的异质性,并突出了单细胞转录组学在解析造血祖细胞间细胞异质性和发育关系方面的有效性。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验